Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1996 Oct;49(10):791–794. doi: 10.1136/jcp.49.10.791

Immunohistochemical evaluation of keratin 20 expression in intestinal metaplasia types I to III.

M J Schwerer 1, K Baczako 1
PMCID: PMC500769  PMID: 8943741

Abstract

AIMS: To investigate differences in expression of keratin 20, a cytoskeletal protein in gastrointestinal epithelial cells, in completely differentiated intestinal metaplasia (type I) and incomplete metaplasia (types II and III). METHODS: Gastric biopsy specimens from 66 patients with intestinal metaplasia were analysed immunohistochemically. Expression of keratin 20 was quantified as the percentage of immunoreactive cells on the tips, the upper, and deep foveolae. RESULTS: In all specimens keratin 20 was found on the tips and in the upper foveolae of intestinal metaplasia. Keratin 20 was not observed in the deep foveolae. No differences were seen between the antrum and the body. Expression patterns were comparable between types I and III. In type II, however, lower immunoreactivity was found. Both the differences between types I and II as well as between types II and III were significant (p < 0.05). CONCLUSIONS: Keratin 20 is expressed in metaplastic mucosa as a result of intestinal differentiation. Positive staining found exclusively in juxtaluminal cells occurs only in mature cells containing keratin 20. Lowered immunoreactivity in type II compared with types I and III indicates the different nature of type II intestinal metaplasia. Further studies are needed to shed light on the basic fundamental mechanism responsible for this.

Full text

PDF
791

Images in this article

792Image
on p.792
793Image
on p.793

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antonioli D. A. Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer. Hum Pathol. 1994 Oct;25(10):994–1005. doi: 10.1016/0046-8177(94)90058-2. [DOI] [PubMed] [Google Scholar]
  2. Appelman H. D. Gastritis: terminology, etiology, and clinicopathological correlations: another biased view. Hum Pathol. 1994 Oct;25(10):1006–1019. doi: 10.1016/0046-8177(94)90059-0. [DOI] [PubMed] [Google Scholar]
  3. Calnek D., Quaroni A. Changes in keratin expression during fetal and postnatal development of intestinal epithelial cells. Biochem J. 1992 Aug 1;285(Pt 3):939–946. doi: 10.1042/bj2850939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Calnek D., Quaroni A. Differential localization by in situ hybridization of distinct keratin mRNA species during intestinal epithelial cell development and differentiation. Differentiation. 1993 Jun;53(2):95–104. doi: 10.1111/j.1432-0436.1993.tb00649.x. [DOI] [PubMed] [Google Scholar]
  5. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988 Jul 1;48(13):3554–3560. [PubMed] [Google Scholar]
  6. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19 (Suppl 1):S37–S43. [PubMed] [Google Scholar]
  7. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992 Dec 15;52(24):6735–6740. [PubMed] [Google Scholar]
  8. Craanen M. E., Blok P., Dekker W., Offerhaus G. J., Tytgat G. N. Chronology of p53 protein accumulation in gastric carcinogenesis. Gut. 1995 Jun;36(6):848–852. doi: 10.1136/gut.36.6.848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Craanen M. E., Dekker W., Blok P., Ferwerda J., Tytgat G. N. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut. 1992 Jan;33(1):16–20. doi: 10.1136/gut.33.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Eidt S., Stolte M. Antral intestinal metaplasia in Helicobacter pylori gastritis. Digestion. 1994;55(1):13–18. doi: 10.1159/000201116. [DOI] [PubMed] [Google Scholar]
  11. Gordon J. I., Hermiston M. L. Differentiation and self-renewal in the mouse gastrointestinal epithelium. Curr Opin Cell Biol. 1994 Dec;6(6):795–803. doi: 10.1016/0955-0674(94)90047-7. [DOI] [PubMed] [Google Scholar]
  12. Hazelbag H. M., van den Broek L. J., van Dorst E. B., Offerhaus G. J., Fleuren G. J., Hogendoorn P. C. Immunostaining of chain-specific keratins on formalin-fixed, paraffin-embedded tissues: a comparison of various antigen retrieval systems using microwave heating and proteolytic pre-treatments. J Histochem Cytochem. 1995 Apr;43(4):429–437. doi: 10.1177/43.4.7534785. [DOI] [PubMed] [Google Scholar]
  13. Higgins P. J., Correa P., Cuello C., Lipkin M. Fetal antigens in the precursor stages of gastric cancer. Oncology. 1984;41(2):73–76. doi: 10.1159/000225796. [DOI] [PubMed] [Google Scholar]
  14. Iida F., Murata F., Nagata T. Histochemical studies of mucosubstances in metaplastic epithelium of the stomach, with special reference to the development of intestinal metaplasia. Histochemistry. 1978 Jul 12;56(3-4):229–237. doi: 10.1007/BF00495984. [DOI] [PubMed] [Google Scholar]
  15. Jass J. R. Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J Clin Pathol. 1980 Sep;33(9):801–810. doi: 10.1136/jcp.33.9.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Matsukuma A., Mori M., Enjoji M. Sulphomucin-secreting intestinal metaplasia in the human gastric mucosa. An association with intestinal-type gastric carcinoma. Cancer. 1990 Aug 15;66(4):689–694. doi: 10.1002/1097-0142(19900815)66:4<689::aid-cncr2820660417>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  17. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol. 1995 May;8(4):384–388. [PubMed] [Google Scholar]
  18. Moll R., Franke W. W., Schiller D. L., Geiger B., Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982 Nov;31(1):11–24. doi: 10.1016/0092-8674(82)90400-7. [DOI] [PubMed] [Google Scholar]
  19. Moll R., Löwe A., Laufer J., Franke W. W. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992 Feb;140(2):427–447. [PMC free article] [PubMed] [Google Scholar]
  20. Moll R., Schiller D. L., Franke W. W. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol. 1990 Aug;111(2):567–580. doi: 10.1083/jcb.111.2.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Moll R., Zimbelmann R., Goldschmidt M. D., Keith M., Laufer J., Kasper M., Koch P. J., Franke W. W. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation. 1993 Jun;53(2):75–93. doi: 10.1111/j.1432-0436.1993.tb00648.x. [DOI] [PubMed] [Google Scholar]
  22. Nardelli J., Bara J., Rosa B., Burtin P. Intestinal metaplasia and carcinomas of the human stomach: an immunohistological study. J Histochem Cytochem. 1983 Mar;31(3):366–375. doi: 10.1177/31.3.6338105. [DOI] [PubMed] [Google Scholar]
  23. Osborn M., Mazzoleni G., Santini D., Marrano D., Martinelli G., Weber K. Villin, intestinal brush border hydrolases and keratin polypeptides in intestinal metaplasia and gastric cancer; an immunohistologic study emphasizing the different degrees of intestinal and gastric differentiation in signet ring cell carcinomas. Virchows Arch A Pathol Anat Histopathol. 1988;413(4):303–312. doi: 10.1007/BF00783022. [DOI] [PubMed] [Google Scholar]
  24. Owen D. A. Normal histology of the stomach. Am J Surg Pathol. 1986 Jan;10(1):48–61. doi: 10.1097/00000478-198601000-00006. [DOI] [PubMed] [Google Scholar]
  25. Quaroni A., Calnek D., Quaroni E., Chandler J. S. Keratin expression in rat intestinal crypt and villus cells. Analysis with a panel of monoclonal antibodies. J Biol Chem. 1991 Jun 25;266(18):11923–11931. [PubMed] [Google Scholar]
  26. Quinlan R. A., Schiller D. L., Hatzfeld M., Achtstätter T., Moll R., Jorcano J. L., Magin T. M., Franke W. W. Patterns of expression and organization of cytokeratin intermediate filaments. Ann N Y Acad Sci. 1985;455:282–306. doi: 10.1111/j.1749-6632.1985.tb50418.x. [DOI] [PubMed] [Google Scholar]
  27. SPICER S. S. DIAMINE METHODS FOR DIFFERENTIALING MUCOSUBSTANCES HISTOCHEMICALLY. J Histochem Cytochem. 1965 Mar;13:211–234. doi: 10.1177/13.3.211. [DOI] [PubMed] [Google Scholar]
  28. Shi S. R., Key M. E., Kalra K. L. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 1991 Jun;39(6):741–748. doi: 10.1177/39.6.1709656. [DOI] [PubMed] [Google Scholar]
  29. Stemmermann G., Heffelfinger S. C., Noffsinger A., Hui Y. Z., Miller M. A., Fenoglio-Preiser C. M. The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum Pathol. 1994 Oct;25(10):968–981. doi: 10.1016/0046-8177(94)90056-6. [DOI] [PubMed] [Google Scholar]
  30. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol. 1993;119(5):265–272. doi: 10.1007/BF01212724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tosi P., Filipe M. I., Baak J. P., Luzi P., Santopietro R., Miracco C., Sforza V., Megha T. Morphometric definition and grading of gastric intestinal metaplasia. J Pathol. 1990 Jul;161(3):201–208. doi: 10.1002/path.1711610306. [DOI] [PubMed] [Google Scholar]
  32. Tosi P., Filipe M. I., Luzi P., Miracco C., Santopietro R., Lio R., Sforza V., Barbini P. Gastric intestinal metaplasia type III cases are classified as low-grade dysplasia on the basis of morphometry. J Pathol. 1993 Jan;169(1):73–78. doi: 10.1002/path.1711690112. [DOI] [PubMed] [Google Scholar]
  33. Tseng S. C., Jarvinen M. J., Nelson W. G., Huang J. W., Woodcock-Mitchell J., Sun T. T. Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell. 1982 Sep;30(2):361–372. doi: 10.1016/0092-8674(82)90234-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES